ADMA Biologics Stock Forecast - Daily Balance Of Power

ADMA Stock  USD 17.40  0.50  2.79%   
ADMA Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast ADMA Biologics stock prices and determine the direction of ADMA Biologics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of ADMA Biologics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, ADMA Biologics' Inventory Turnover is projected to increase slightly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 11.35, whereas Fixed Asset Turnover is forecasted to decline to 2.45. . The current year's Common Stock Shares Outstanding is expected to grow to about 235.2 M, whereas Net Loss is forecasted to decline to (62.3 M).
On September 9, 2024 ADMA Biologics had Daily Balance Of Power of 0.4731. Balance of Power indicator (or BOP) measures the strength of ADMA Biologics market sensitivity to bulls and bears. It estimates the ability of ADMA Biologics buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring ADMA Biologics Balance of Power indicator one can determine a trend of the price direction.
Check ADMA Biologics VolatilityBacktest ADMA BiologicsTrend Details  

ADMA Biologics Trading Date Momentum

On September 10 2024 ADMA Biologics was traded for  17.29  at the closing time. The top price for the day was 18.52  and the lowest listed price was  16.94 . The trading volume for the day was 5.8 M. The trading history from September 10, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.93% . The overall trading delta against the current closing price is 0.60% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare ADMA Biologics to competition

Other Forecasting Options for ADMA Biologics

For every potential investor in ADMA, whether a beginner or expert, ADMA Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ADMA Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ADMA. Basic forecasting techniques help filter out the noise by identifying ADMA Biologics' price trends.

View ADMA Biologics Related Equities

 Risk & Return  Correlation

ADMA Biologics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ADMA Biologics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ADMA Biologics' current price.

ADMA Biologics Market Strength Events

Market strength indicators help investors to evaluate how ADMA Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ADMA Biologics shares will generate the highest return on investment. By undertsting and applying ADMA Biologics stock market strength indicators, traders can identify ADMA Biologics entry and exit signals to maximize returns.

ADMA Biologics Risk Indicators

The analysis of ADMA Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ADMA Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting adma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ADMA Biologics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ADMA Biologics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Adma Biologics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Adma Biologics Stock:
Check out Historical Fundamental Analysis of ADMA Biologics to cross-verify your projections.
For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
14
Earnings Share
0.27
Revenue Per Share
1.661
Quarterly Revenue Growth
0.781
Return On Assets
0.1989
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.